A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
Recruiting
Observational Study
Chronic Rhinosinusitis With Nasal Polyps
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- AstraZeneca · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective, multicenter real-world study to describe the postoperative outcomes and quality of life, disease control and characteristics of patients who underwent surgery, as well as economic burden and post-operative treatment patterns in Chinese patients with CRSwNP recurrence.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Participant must be 16 years of age or older, at the time of signing the informed consent.
2. Participants with a documented diagnosis of CRSwNP.
3. Endoscopic nasal polypectomy is performed during the screening period.
4. Voluntarily participate and sign the informed consent…
Contacts
AstraZeneca Clinical Study Information Center
1-877-240-9479
information.center@astrazeneca.com
CONTACT